Imugene Market Cap

Imugene has a market cap or net worth of 171.74 million as of May 15, 2025. Its market cap has decreased by -72.40% in one year.

Market Cap

171.74M

Enterprise Value

153.76M

Revenue

-1.84M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.02

Market Cap Chart

Since September 17, 2002, Imugene's market cap has increased from 7.38M to 171.74M, an increase of 2,227.51%. That is a compound annual growth rate of 14.89%.

Market Cap History

Date	Market Cap	% Change
May 14, 2025	171.74M	-37.59%
Dec 31, 2024	275.18M	-65.11%
Dec 29, 2023	788.60M	-15.31%
Dec 30, 2022	931.15M	-59.62%
Dec 31, 2021	2.31B	386.45%
Dec 31, 2020	474.09M	234.74%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CSL Limited	116.59B
Pro Medicus	27.70B
Cochlear	17.60B
Sonic Healthcare	12.82B
Telix Pharmaceuticals	8.57B
Ramsay Health Care	8.39B
Ansell	4.68B
Regis Healthcare	2.33B

Market Cap Rankings